Toxigenic Vibrio cholerae identified in estuaries of Tanzania using PCR techniques

FEMS Microbiology Letters
Lucy DalusiSara Sjöling

Abstract

The current study assessed the occurrence of the Vibrio cholerae serogroups O1 and O139 in environmental samples along salinity gradients in three selected estuaries of Tanzania both through culture independent methods and by cultured bacteria. Occurrence of V. cholerae was determined by PCR targeting the V. cholerae outer membrane protein gene ompW. Furthermore, the presence of toxigenic strains and serogroups O1 and O139 was determined using multiplex PCR with specific primers targeting the cholera toxin gene subunit A, ctxA, and serotype specific primers, O1-rfb and O139-rfb, respectively. Results showed that V. cholerae occurred in approximately 10% (n = 185) of both the environmental samples and isolated bacteria. Eight of the bacteria isolates (n = 43) were confirmed as serogroup O1 while one belonged to serogroup O139, the first reported identification of this epidemic strain in East African coastal waters. All samples identified as serogroup O1 or O139 and a number of non-O1/O139 strains were ctxA positive. This study provides in situ evidence of the presence of pathogenic V. cholerae O1 and O139 and a number of V. cholerae non-O1/O139 that carry the cholera toxin gene in estuaries along the coast of Tanzania.

References

Jan 1, 1979·Applied and Environmental Microbiology·J KaperS W Joseph
Jun 1, 1990·Applied and Environmental Microbiology·M L TamplinR R Colwell
May 29, 1982·Lancet·C J MillerR G Feachem
Jan 1, 1983·Applied and Environmental Microbiology·A HuqR R Colwell
Feb 1, 1981·Applied and Environmental Microbiology·R R ColwellA Huq
Jan 1, 1995·Clinical Microbiology Reviews·J B KaperM M Levine
Oct 1, 1994·Clinical Microbiology Reviews·S R Rippey
Jan 1, 1997·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·R J Borroto
Aug 31, 2000·Applied and Environmental Microbiology·S ChakrabortyG B Nair
May 26, 2001·Applied and Environmental Microbiology·I N RiveraR R Colwell
Jun 6, 2003·Applied and Environmental Microbiology·Erin K LippRita R Colwell
Jul 16, 2003·Journal of Applied Microbiology·Indrani KarunasagarR R Colwell
Jul 9, 2004·Applied and Environmental Microbiology·Janelle R ThompsonMartin F Polz
Dec 3, 2004·Applied and Environmental Microbiology·Norma BinszteinRita Colwell
Apr 7, 2006·Applied and Environmental Microbiology·Munirul AlamRita R Colwell
Dec 22, 2006·Journal of Clinical Microbiology·Yael Danin-PolegYechezkel Kashi
Sep 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Melissa Tobin-D'AngeloEric Mintz
Sep 17, 2009·Nature Reviews. Microbiology·Eric J NelsonAndrew Camilli
Aug 5, 2010·The American Journal of Tropical Medicine and Hygiene·Daniel R FeikinJohn Gichuki
Oct 29, 2010·Environmental Health Perspectives·Masahiro HashizumeKazuhiko Moji
Jun 3, 2011·The American Journal of Tropical Medicine and Hygiene·Rita ReyburnMohammad Ali
Feb 1, 2010·Environmental Microbiology Reports·Luigi VezzulliRita R Colwell
Sep 11, 2013·The American Journal of Tropical Medicine and Hygiene·Ali Shafqat AkandaShafiqul Islam
Jan 1, 2014·Frontiers in Microbiology·Carla LutzDiane McDougald

❮ Previous
Next ❯

Citations

Jun 3, 2017·International Journal of Environmental Health Research·Madhumanti HalderAnup Palit
May 24, 2018·Letters in Applied Microbiology·I Guardiola-AvilaV Bocanegra-García
May 23, 2019·Frontiers in Microbiology·Yaovi M Gildas HounmanouAnders Dalsgaard
Jun 24, 2018·Frontiers of Medicine·Ali A Rabaan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.